Source: International Congress 2018 – Role of omics in population studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), L. Lahousse (Ghent, Belgium), B. Stricker (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium). ß2-adrenergic receptor polymorphisms and risk of COPD. 1270

Member's Comments

No comment yet.

Related content which might interest you: CTLA4 polymorphisms and COPD Source: Eur Respir J 2010; 35: 457-458 Year: 2010 IFNL3 polymorphisms are associated with COPD severity and outcomes Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 The GSTs polymorphisms and risk for COPD in a Brazilian population Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 Source: Eur Respir J 2006; 27: 682-688 Year: 2006 G-protein coupled receptor gene polymorphism is associated with asthma and asthma severity in Russian patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Polymorphisms of the beta adrenoceptor are associated with severity of disease, but not disease susceptibility, in subjects with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 378s Year: 2002 Polymorphisms in EPHX1 and risk of COPD and asthma in 47,000 individuals Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Role of TRPM8 polymorphisms in predisposition to COPD development in smokers Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 The pharmacogenetic effect of ADRB2 polymorphisms on therapeutic response in COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 The human leptin receptor gene Gln223Arg polymorphism and the presence of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 537s Year: 2003 ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study Source: International Congress 2019 – Genes and environment Year: 2019 Arg16Gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Clustering of patients with bronchial asthma with regard to the genotypes for Bcl1 polymorphism in the glucocorticoid receptor gene Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 CCL5 rs2280788 polymorphism increased the risk of COPD in the Belarusian population Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 No association between COPD and ADAM33, TNF, EPHX1 and ADRB2 polymorphisms (SNPs) in a large case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 584s Year: 2006 IL-6 gene polymorphisms associated to COPD in a Spanish population Source: Eur Respir J 2006; 28: Suppl. 50, 584s Year: 2006 Vitamin D receptor polymorphisms and exacerbation frequency in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 VDBP gene polymorphism in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 Association of ER22/23EK glucocorticoid receptor gene polymorphism with glucocorticoids dosage in COPD Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Leptin receptor polymorphisms and lung function decline in COPD Source: Eur Respir J 2009; 34: 103-110 Year: 2009